Cytokinetics

Today is International Clinical Trials Day, a moment to recognize the power of clinical research and the people who make it possible. Watch the video to hear how clinical research professionals at Cytokinetics keep patients at the heart of every study. #InternationalClinicalTrialsDay #TeamCyto

We are excited to see new findings from an analysis of the NHLBI – Heart Research & Education HCM Registry published in JAMA, reflecting the value of long-term clinical research hypertrophic cardiomyopathy (#HCM).  The analysis, “Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy,” provides new insights into risk factors associated with adverse outcomes in patients with HCM.  As a longstanding supporter of the HCM Registry, Cytokinetics recognizes the important role the registry continues to play in contributing to the clinical and scientific understanding of HCM and congratulates the investigators on this important work. Access the publication here on the JAMA website: https://bit.ly/42wbzF1 

We had an incredible time at #HeartFailure2026 in Barcelona! It was a privilege to connect with leading experts, clinicians and patient advocates from around the world.   At Cytokinetics, we are proud to be growing our European team to further support this vital community. These meaningful conversations continue to inspire our mission to improve the lives of people living with cardiovascular diseases.  We look forward to keeping the momentum going at upcoming congresses! #HeartFailure 

Attending Heart Failure 2026 in Barcelona? Visit us at the Cytokinetics booth to talk with our team and learn more about our research & science.   During the conference, we'll also be presenting data, sharing abstracts, and leading a sponsored satellite symposium. We're looking forward to connecting with you! #HeartFailure2026 #HeartFailure

We recently welcomed new colleagues to our Key Account Management and Market Access team in Germany! We hosted our new colleagues alongside senior leaders from across the globe to encourage the open dialogue that defines our culture. However, the true heart of the experience was an afternoon spent learning from a person living with #HCM. This served as the ultimate reminder of our core value—Patients are our North Star—ensuring our mission remains centered on the people we serve from day one. #TeamCyto #Germany

The impact of hypertrophic cardiomyopathy (HCM) can go beyond physical health, affecting emotional wellbeing, too. During #MentalHealthAwarenessMonth, we recognize the full impact of #HCM and stand with those navigating its challenges.

We're excited to be attending ANMCO 2026 May 7–9 in Rimini, Italy. We'll be connecting with the Italian cardiology community at this congress dedicated to sharing knowledge and innovative perspectives. #ANMCO

Today we announced topline results from ACACIA-HCM, our Phase 3 clinical trial in non-obstructive HCM. Learn more in our press release: https://bit.ly/4wc5YBe #HCM #Biopharma

We’re proud to recognize Asian American, Native Hawaiian, and Pacific Islander Heritage Month!  Join us as we celebrate our AANHPI colleagues and partners across the biotech and life sciences ecosystem and beyond.  #AANHPI #AAPI #AANHPIHeritageMonth

Our 3rd annual CLIMB Research Symposium is just around the corner! Taking place on May 29 in San Francisco. CLIMB (Contemporary Landscapes in Muscle Biology) brings together the scientific community to share innovative research in the field of muscle biology. Want to attend? Register today at ClimbSymposium.com. #CLIMB26